Ward, S; Lindsley, A; Courter, J; Assa'ad, A. Clinical testing for COVID-19.. Journal of Allergy and Clinical Immunology. 2020; 146(1):23-34.

Lyles, JL; Martin, LJ; Shoda, T; Collins, MH; Trimarchi, MP; He, H; Kottyan, LC; Mukkada, VA; Rothenberg, ME. Very early onset eosinophilic esophagitis is common, responds to standard therapy, and demonstrates enrichment for CAPN14 genetic variants.. Journal of Allergy and Clinical Immunology. 2021; 147(1):244-254.e6.

Jacobsen, EA; Jackson, DJ; Heffler, E; Mathur, SK; Bredenoord, AJ; Pavord, ID; Akuthota, P; Roufosse, F; Rothenberg, ME. Eosinophil Knockout Humans: Uncovering the Role of Eosinophils Through Eosinophil-Directed Biological Therapies.. Annual Review of Immunology. 2021; 39:719-757.

Risma, KA; Edwards, KM; Hummell, DS; Little, FF; Norton, AE; Stallings, A; Wood, RA; Milner, JD. Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines.. Journal of Allergy and Clinical Immunology. 2021; 147(6):2075-2082.e2.

Azouz, NP; Klingler, AM; Callahan, V; Akhrymuk, IV; Elez, K; Raich, L; Henry, BM; Benoit, JL; Benoit, SW; Noé, F; Kehn-Hall, K; Rothenberg, ME. Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2-Priming Protease TMPRSS2.. Pathogens and Immunity. 2021; 6(1):55-74.